BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6772024)

  • 1. Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts.
    d'Azzo A; Halley DJ; Hoogeveen A; Galjaard H
    Am J Hum Genet; 1980 Jul; 32(4):519-28. PubMed ID: 6772024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency.
    Mueller OT; Shows TB
    Hum Genet; 1982; 60(2):158-62. PubMed ID: 7076257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants.
    Shows TB; Mueller OT; Honey NK; Wright CE; Miller AL
    Am J Med Genet; 1982 Jul; 12(3):343-53. PubMed ID: 6287841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion with enucleated fibroblasts corrects "I-cell" defect.
    D'Azzo A; Konings A; Verkerk A; Jongkind JF; Galjaard H
    Exp Cell Res; 1980 Jun; 127(2):484-7. PubMed ID: 6769689
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts.
    Strisciuglio P; Creek KE; Sly WS
    Pediatr Res; 1984 Feb; 18(2):167-71. PubMed ID: 6422434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complementation of beta-galactosidase in fused cells of mucolipidosis II with another variants of beta-galactosidase deficiency using new single cell enzyme assay.
    Okada S; Kato T; Yabuuchi H; Okada Y
    Biochem Biophys Res Commun; 1979 May; 88(2):559-62. PubMed ID: 111672
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecific genetic complementation analysis of human and sheep fibroblasts with beta-galactosidase deficiency.
    Ahern-Rindell AJ; Murnane RD; Prieur DJ
    Somat Cell Mol Genet; 1989 Nov; 15(6):525-33. PubMed ID: 2512653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes.
    Miller AL; Kress BC; Stein R; Kinnon C; Kern H; Schneider JA; Harms E
    J Biol Chem; 1981 Sep; 256(17):9352-62. PubMed ID: 7263719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult type GMl-gangliosidosis: a complementation study on somatic cell hybrids.
    Suzuki Y; Furukawa T; Hoogeveen A; Verheijen F; Galjaard H
    Brain Dev; 1979; 1(2):83-6. PubMed ID: 121869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lysosomal enzymes in human mutant fibroblast-chick erythrocyte heterokaryons.
    Van der Veer E; Barneveld RA; Reuser AJ
    Exp Cell Res; 1982 Nov; 142(1):235-45. PubMed ID: 6291965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sucrose loading on lysosomal hydrolases.
    Kato T; Okada S; Yutaka T; Yabuuchi H
    Mol Cell Biochem; 1984; 60(1):83-98. PubMed ID: 6708943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic abnormalities of lysosomal enzymes in mucolipidosis fibroblast lines.
    Champion MJ; Shows TB
    Am J Hum Genet; 1977 Mar; 29(2):149-63. PubMed ID: 848490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro establishment of human fibroblasts of lysosomal diseases, GM1-gangliosidosis and Sandhoff disease, by transformation with origin-minus SV40 DNA.
    Momoi T; Furuya T; Suzuki Y; Sato H; Yamaguchi N
    Biosci Rep; 1985 Mar; 5(3):267-73. PubMed ID: 2990594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of lysosomal enzymes in cultured normal and sialidosis type II human fibroblasts and the effect of ammonium chloride on this heterogeneity.
    Heyworth CM; Wynn CH
    Mol Cell Biochem; 1985 May; 67(1):25-30. PubMed ID: 3160928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.
    Mueller OT; Honey NK; Little LE; Miller AL; Shows TB
    J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation studies with enucleated fibroblasts from different variants of beta-galactosidase deficiency.
    de Wit-Verbeek HA; Hoogeveen A; Galjaard H
    Exp Cell Res; 1978 Apr; 113(1):215-8. PubMed ID: 416963
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.
    Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H
    Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.